July 2010
Medicom to distribute DySIS in Serbia, Bosnia-Herzegovina and Montenegro
Medicom has signed an exclusive distributor agreement for DySIS with Forth Photonics, covering Serbia, Bosnia-Herzegovina and Montenegro. The agreement marks the beginning of what will certainly be a very succesful collaboration that will bring DySIS into the clinics and practices of gynecologists of the region. |
July 2010
Forth Photonics signs agreement with Antisel to distribute DySIS in Bulgaria and Romania
Forth Photonics is happy to announce that ANTISEL SA has
signed exclusive distributor agreements for DySIS in Bulgaria and Romania.
Following the very successful launch of DySIS at the Bulgarian 15th National congress of Gynaecological Oncology in April and with the support of Antisel, DySIS will make an impact and help Bulgarian gynecologists to increase their detetion rate for cervical neoplasia.
With the first DySIS being installed in Romania later this month,
the agreement with Antisel is expected to boost further growth in a country where cervical cancer occurs at an alarming rate, calling for new approaches to the problem. |
May 2010
DySIS presented at the 5th European Congress of the EFC
DySIS will be presented at the 5th European Congress of the European Federation of Colposcopy in Berlin (May 27-30). Come to our exhibition booth (#5 in the Potsdam-II hall) to see DySIS and discuss the clinical benefits it will offer you!!!
Visitors will also have the opportunity to discuss clinical study results during the poster sessions (Foyer Potsdam) with J. Louwers from the VUMC in Amsterdam, the Netherlands and P. Tsetsa from the Alexandra hospital in Athens, Greece. |
April 2010
DySIS at the 15th National conference of gynaecological
oncology in Bulgaria
DySIS was recently launched in Bulgaria at the 15th National Conference
of Gynaecological Oncology in Veliko Turnovo. There was strong
interest from the delegates and the presentation on DySIS given during
the scientific programme was very well attended. The launch in Bulgaria
shows the continued growth of Forth Photonics and DySIS in Europe. |
March 2010
DySIS at the ASCCP Biennial Meeting
Forth Photonics will be presenting DySIS at the Biennial Meeting of the American Society for Colposcopy and Cervical Pathology (ASCCP) that takes place at the Green Valley Ranch Resort in Las Vegas (March 24-27). Visit our booth for a hands-on demonstration of DySIS! |
February 2010
DySIS at Eurogin 2010
Forth Photonics will be presenting DySIS during Eurogin 2010, which takes place in Monte Carlo (February 17-20). Visit us at the exhibition (booth C4) for a hands-on demonstration of DySIS. |
February 2010
DySIS at the Middle East Obs-Gyne Congress
Forth Photonics joins again the 6th Middle East Obs-Gyne Congress, which this year returns to Dubai (February 14-16) to present DySIS. Visit us at the exhibition to discuss the technology!!! |
November 2009
DySIS distribution in Italy
Forth Photonics announces that it entered a distribution collaboration with Technologic Srl "Hologic Italia" to distribute DySIS in Italy. This collaboration strengthens the presence of Forth Photonics in Europe and gives Italian gynecologists the opportunity to upgrade their practice by embracing the benefits of DySIS. |
November 2009
Sales grow in Greece
Establishing a dedicated sales team in Greece has led to a significant growth of sales. Several private practices are now offering their patients a DySIS examination and numerous women have already been examined by gynecologists using DySIS in major clinics. |
October 2009
DySIS at the 16th International Meeting of the ESGO
Forth Photonics will be presenting the latest version of DySIS at the 16th International Meeting of the European Society of Gynaecological Oncology that takes place in Belgrade (11-14 October). You can visit us at Booth 18 (Hall A) for a demonstration of DySIS.
On Monday, October 12, during the poster session 1 at the poster area, you can discuss clinical results with Jacqueline Louwers from the Netherlands (poster #50). |
April 2009
DySIS at the 2009 BSCCP meeting in Dublin
Forth Photonics will be presenting DySIS at the annual BSCCP meeting taking place in Dubin (7-8 May). Visit us at the exhibition, booth No 11, for a full demonstration of the capabilities of DySIS and to discuss the value it could add to your practice!
Attend the presentation of Mr Pat Soutter on Friday morning (09:45 session), to learn about the potential clinical benefits of using DySIS. |
March 2009
DySIS at the Obs-Gyne 2009 meeting in Abu Dhabi
DySIS will be presented at the upcoming Obs-Gyne Exhibition (1-3 April 2009) in Abu Dhabi, UAE; visit us at stand D-18 for a full demonstration and to discuss how embracing DySIS can improve your colposcopic practice and performance. |
January 2009
Forth Photonics announces funding for further growth
Forth Photonics announces that it has completed its second round of fundraising, with new investment of €7.6m (£6.1m). The newly-raised funds are expected to take Forth Photonics’ first product through to full commercialisation.
Forth Photonics will use the funds to commercialize its medical device, DySIS (Dynamic Spectral Imaging System), which is the only medical device to use dynamic spectral imaging technology to assist gynecologists in the detection and mapping of precancerous and cancerous lesions of the cervix. The usage of DySIS has been shown in clinical trails to significantly increase the sensitivity of pre-cancerous lesion detection compared with traditional methods.
Investors who have participated in this round of fund raising are: NBGI Ventures, Albion Ventures, Scottish Venture Fund.
Fiona Lowrie, Forth Photonics’ Chief Executive, said:
“This funding will allow Forth Photonics to make the DySIS technology available to gynecologists internationally.
“We have ambitious growth plans, built on the solid
foundation of DySIS’ proven capability, and we plan to see DySIS adopted as the standard of care in our target countries.” |
December 2008
ISO 13485:2007 certification
The Quality Management System established and maintained by Forth Photonics as applied in the design, manufacturing and service of digital colposcopes and digital hyper spectral cameras meets the requirements of DIN EN ISO 13485:2007 (Medical devices - Quality Management Systems - Requirements for Regulatory Purposes). The auditing and certification was performed by TUV Nord. |
November 2008
ISO 9001:2000 certification
The Quality Management System of Forth Photonics as applied in the design, manufacture and service of its products received an ISO 9001:2000 certification. The auditing and certification was performed by TUV Nord. |
October 2008
Forth Photonics at Eurogin 2008
Forth Photonics will be at the upcoming Eurogin congress in Nice, France. Visit us at booth #4 in the exhibition hall for a full demonstration of DySIS.
On Saturday, November 15th (Session SS21, 14:15, Room Calliope) you can attend the presentation of Mr P. Soutter on the clinical results of dynamic spectral imaging. |
September 2008
Forth Photonics agrees distributorship with Eurosurgical Ltd
in Ireland
Forth Photonics are delighted to announce a distribution partnership with Eurosurgical Ltd of Ireland. The depth and breadth of Eurosurgical’s expertise will enable Forth Photonics to deliver DySIS across Ireland. Commenting on the partnership Fiona Lowrie (CEO - Forth Photonics) said “There is a natural synergy between DySIS and the high quality portfolio Eurosurgical work with. We are extremely happy that we have secured a agreement with an organisation focused on delivering quality service and value to their customers”.
Ray Kane (Managing Director - Eurosurgical Ltd) commented “We are excited at the prospect of working with Forth Photonics and for the opportunity such a partnership affords Eurosurgical to become an integral part in the future delivery of colposcopy services across Ireland. Given Eurosurgical’s high profile in the field of Gynaecology, the addition of DySIS to our established product portfolio further enhances our position as one of the leading specialist companies in this area”.
In addition to their extensive experience in the area of colposcopy Eurosurgical have a dedicated team of support engineers who will assist in the deployment of DySIS across Ireland. |
July 2008
Sloane Street Gynaecology Clinic integrates DySIS
Thomas Ind has become the first private sector practice in the UK to be a Forth Photonics' customer. Thomas will use the DySIS medical imaging system in his colposcopy clinic in Sloane Street, London. Commenting on the integration of DySIS, Thomas Ind said "At the Sloane St Colposcopy Clinic we have always been committed to adopting the most advanced technology to ensure the highest standards of patient care. DySIS is the next generation of colposcopic equipment.
It provides quantitative information that helps me in the early detection of pre-cancerous and cancerous lesions of the cervix." |
May 2008
Forth Photonics locates in Scotland and builds its UK sales & marketing infrastructure
In the UK Forth Photonics have head-quartered the company in Edinburgh and have recruited key field-based staff to build clinical acceptance for the DySIS imaging system and support commercialization of the product. |
May 2008
Forth Photonics agrees distributorship with Medical Dynamics in the Netherlands
Forth Photonics has concluded an agreement with Medical Dynamics whereby Medical Dynamics will distribute DySIS imaging systems in the Netherlands. Under this agreement the first two DySIS imaging systems have been sold to hospitals in the Netherlands. |
April 2008
Forth Photonics sells first DySIS imaging systems in Europe
Forth Photonics have sold the first DySIS imaging systems into hospitals
in Greece and Ireland. The DySIS imaging system is used by doctors to assist in their diagnosis of cervical cancer and pre-cancerous lesions. |
April 2008
The British Society for Colposcopy & Cervical Pathology
DySIS was presented at the annual scientific meeting of the British Society for Colposcopy and Cervical Pathology (BSCCP) in Birmingham (10-11 April). The oral presentation given by Prof. Balas received a conference award. |
March 2008
American Society for Colposcopy and Cervical Pathology
Forth Photonics presented DySIS at the biennial meeting of the American Society for Colposcopy and Cervical Pathology (ASCCP) that took place in Lake Buena Vista, Florida (March 17-21). The company booth enjoyed a high attendance and DySIS received very positive feedback. |
January, 2008
Fiona Lowrie appointed as the CEO of FORTH PHOTONICS
Fiona Lowrie joined FORTH Photonics to lead the company’s new phase of expansion and growth. |
October, 2007
Eurogin 2007 Congress
Forth Photonics participated in The Eurogin 2007 Congress (4th – 6th of October 2007) in Monte Carlo. An oral presentation was held on the 4th of October at 17:15 (Management session, Salle Bosio) by Prof. Balas. DySIS was displayed at the company booth and enjoyed a high attendance. |
September, 2007
4th European Congress for Colposcopy and Cervical Pathology
Forth Photonics participated in the 4th European congress for colposcopy and cervical pathology in Belgrade (20th – 22th of September 2007). |
July, 2007
The British International Congress of Obstetrics and Gynaecology
DySIS technology received the “Best Poster Award”, a distinction awarded by the conference scientific committee. |
July, 2007
The British International Congress of Obstetrics and Gynaecology
Forth Photonics participated in The British International Congress of Obstetrics and Gynaecology in London (4th – 6th of July 2007).
DySIS was presented at the company booth. |
April, 2007
The British Society for Colposcopy & Cervical Pathology
The DySIS technology together with its clinical performance characteristics were presented by the Forth Photonics R&D team and the clinical investigators team at The British Society for Colposcopy & Cervical Pathology in Sheffield (12th-14th of April, 2007). In addition, DySIS was displayed at the company booth and enjoyed a high attendance. |
March, 2007
CE-Mark regulatory clearance
Forth Photonics announces that DySIS imaging technology for colposcopy received CE-Mark regulatory clearance for EU and affiliated countries.
The company has initiated procedures for FDA clearance. |
January, 2007
Clinical trial completed
Forth Photonics announces the completion of a large clinical trial sponsored by the company. 447 women enrolled in the trial, performed at Hammersmith and Saint Mary’s Hospitals (London) and at Alexandra Hospital (Athens). The purpose of the trial was to compare the performances of cytology, colposcopy and DySIS imaging technology in discriminating high from non-high grade cervical neoplasia.
The company proudly announces that DySIS demonstrated
a performance significantly superior than that of both cytology and colposcopy. |
